{"content":"<li class=\"n-box-item date-title\" data-end=\"1481518799\" data-start=\"1481432400\" data-txt=\"Sunday, December 22, 2019\">Sunday, December 11, 2016</li><li class=\"n-box-item sa-box-item\" data-id=\"3229868\" data-ts=\"1481513339\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKAO\" target=\"_blank\">AKAO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3229868-achaogen-to-host-conference-call-tomorrow-morning-on-plazomicin-phase-3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Achaogen to host conference call tomorrow morning on plazomicin Phase 3 results</a></h4><ul>\n<li>Biotech investors will not have to wait long to see some action tomorrow. At 8:30 am ET, thinly traded micro cap Achaogen (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AKAO\" title=\"Achaogen\">AKAO</a>) will host a <a href=\"http://investors.achaogen.com/releasedetail.cfm?ReleaseID=1003644\" target=\"_blank\">conference call</a> to discuss Phase 3 results for lead product candidate plazomicin, an aminoglycoside antibiotic.</li>\n<li>The primary study, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02486627?term=plazomicin&amp;phase=2&amp;rank=1\" target=\"_blank\">EPIC</a>, comparing plazomicin against meropenem for the treatment of complicated urinary tract infection, is expected to serve as a single registration trial to support marketing applications in the U.S. and Europe. A second Phase 3 with a similar timeline, <a href=\"https://clinicaltrials.gov/ct2/show/NCT01970371?term=plazomicin&amp;phase=2&amp;rank=2\" target=\"_blank\">CARE</a>, is a supportive study in patients with serious bacterial infections due to carbapenem-resistant Enterobacteriaceae.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3229868\" data-linked=\"Achaogen to host conference call tomorrow morning on plazomicin Phase 3 results\" data-tweet=\"$AKAO - Achaogen to host conference call tomorrow morning on plazomicin Phase 3 results https://seekingalpha.com/news/3229868-achaogen-to-host-conference-call-tomorrow-morning-on-plazomicin-phase-3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3229868-achaogen-to-host-conference-call-tomorrow-morning-on-plazomicin-phase-3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":1,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}